Manage methamphetamine-associated cardiomyopathy by promoting abstinence in addition to the use of pharmacotherapies

AbstractMethamphetamine-associated cardiomyopathy (MAC) is on the rise. The treatment guidelines for heart failure do not fully take into consideration the comorbidities that are common in patients with MAC, and the safety and efficacy of recommended pharmacotherapies is unproven in these patients. Instead, achieving and maintaining abstinence from methamphetamine is the most important factor for recovery from MAC, and this requires a multidisciplinary approach which involves pharmaceutical interventions and psychosocial support.
Source: Drugs and Therapy Perspectives - Category: Drugs & Pharmacology Source Type: research